Testmiljö
Observera att detta är en testmiljö för utveckling som inte ska användas som underlag för klinisk bedömning. Besök Janusmed här: https://janusmed.se

11/21/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Acetylsalicylsyra Teva

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Acetylsalicylsyra – lågdos Testmiljö

Acetylsalicylsyra – lågdos

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. UKTIS. Use of aspirin and aspirin overdose in pregnancy. July 2019. UKTIS [www]. UKTIS. [cited 2023-04-17].

  2. Czeizel A E, Rockenbauer M, Mosonyi A. A population-based case-control teratologic study of acetylsalicylic acid treatments during pregnancy. Pharmacoepidemiol Drug Saf. 2000;9(3):193-205.

  3. Kozer E, Nikfar S, Costei A et al. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002;187:1623-30.

  4. Werler MM, Sheehan JE, Mitchell AA. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 2002;155:26-31.

  5. Abe K, Honein MA, Moore CA. Maternal febrile illness, medication use, and the risk of congenital renal anomalies. Birth Defets Research Part A 2003;67:911-8.

  6. Luteijn JM, Brown MJ, Dolk H. Influenza and congenital anomalies: a systematic review and meta-analysis. Hum Reprod. 2014;29(4):809-23.

  7. Garza-Galvan M E, Ferrigno A S, Campos-Zamora M, Bain P A, Rae Easter S, Kim J, Figueras F, Farber M K, Lumbreras-Marquez M I. Low-dose aspirin use in the first trimester of pregnancy and odds of congenital anomalies: A meta-analysis of randomized controlled trials. Int J Gynaecol Obstet. 2023;2(160):526-537.

  8. Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019;2019(10):CD004659.

  9. Choi YJ, Shin S. Aspirin Prophylaxis During Pregnancy: A Systematic Review and Meta-Analysis. Am J Prev Med. 2021;61(1):e31-e45.

  10. Landman AJEMC, van Limburg Stirum EVJ, de Boer MA, van 't Hooft J, Ket JCF, Leemhuis AG et al. Long-term health and neurodevelopment in children after antenatal exposure to low-dose aspirin for the prevention of preeclampsia and fetal growth restriction: A systematic review of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2021;267(0):213-220.

  11. Grab D, Paulus WE, Erdmann M, Terinde R, Oberhoffer R, Lang D et al. Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial. Ultrasound Obstet Gynecol. 2000;15(1):19-27.

  12. James AH, Brancazio LR, Price T. Aspirin and reproductive outcomes. Obstet Gynecol Surv. 2008;63(1):49-57.

  13. Maher JE, Owen J, Hauth J, Goldenberg R, Parker CR, Copper RL. The effect of low-dose aspirin on fetal urine output and amniotic fluid volume. Am J Obstet Gynecol. 1993;169(4):885-8.

  1. UKTIS. Use of aspirin and aspirin overdose in pregnancy. July 2019. UKTIS [www]. UKTIS. [cited 2023-04-17].
  2. Czeizel A E, Rockenbauer M, Mosonyi A. A population-based case-control teratologic study of acetylsalicylic acid treatments during pregnancy. Pharmacoepidemiol Drug Saf. 2000;9(3):193-205.
  3. Kozer E, Nikfar S, Costei A et al. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002;187:1623-30.
  4. Werler MM, Sheehan JE, Mitchell AA. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 2002;155:26-31.
  5. Abe K, Honein MA, Moore CA. Maternal febrile illness, medication use, and the risk of congenital renal anomalies. Birth Defets Research Part A 2003;67:911-8.
  6. Luteijn JM, Brown MJ, Dolk H. Influenza and congenital anomalies: a systematic review and meta-analysis. Hum Reprod. 2014;29(4):809-23.
  7. Garza-Galvan M E, Ferrigno A S, Campos-Zamora M, Bain P A, Rae Easter S, Kim J, Figueras F, Farber M K, Lumbreras-Marquez M I. Low-dose aspirin use in the first trimester of pregnancy and odds of congenital anomalies: A meta-analysis of randomized controlled trials. Int J Gynaecol Obstet. 2023;2(160):526-537.
  8. Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019;2019(10):CD004659.
  9. Choi YJ, Shin S. Aspirin Prophylaxis During Pregnancy: A Systematic Review and Meta-Analysis. Am J Prev Med. 2021;61(1):e31-e45.
  10. Landman AJEMC, van Limburg Stirum EVJ, de Boer MA, van 't Hooft J, Ket JCF, Leemhuis AG et al. Long-term health and neurodevelopment in children after antenatal exposure to low-dose aspirin for the prevention of preeclampsia and fetal growth restriction: A systematic review of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2021;267(0):213-220.
  11. Grab D, Paulus WE, Erdmann M, Terinde R, Oberhoffer R, Lang D et al. Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial. Ultrasound Obstet Gynecol. 2000;15(1):19-27.
  12. James AH, Brancazio LR, Price T. Aspirin and reproductive outcomes. Obstet Gynecol Surv. 2008;63(1):49-57.
  13. Maher JE, Owen J, Hauth J, Goldenberg R, Parker CR, Copper RL. The effect of low-dose aspirin on fetal urine output and amniotic fluid volume. Am J Obstet Gynecol. 1993;169(4):885-8.